Description

Lamal Tablets 25 mg. №30

Ingredients

Composition: Each tablet contains 25 mg of Lamal (active ingredient). Other ingredients include microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, and magnesium stearate.

Mechanism of Action

Pharmacodynamics: Lamal (tramadol) is a centrally acting analgesic with a dual mechanism of action. It acts as a weak μ-opioid receptor agonist and inhibits the reuptake of serotonin and norepinephrine, providing effective pain relief in various pain conditions.

Indications for Use

Indications: Lamal tablets are indicated for the treatment of moderate to severe pain, including post-operative pain, cancer pain, and chronic pain syndromes.

Contraindications

Contraindications: Do not use Lamal tablets if allergic to Lamal or any other ingredients. Contraindicated in patients with respiratory depression, acute or severe bronchial asthma, and paralytic ileus.

Side Effects

Side Effects: Common side effects may include nausea, dizziness, constipation, and headache. Severe side effects like respiratory depression and allergic reactions may occur in rare cases.

Usage Instructions

Dosage: The recommended dosage is one tablet (25 mg) daily. Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet. Follow the instructions provided by your healthcare provider.

Benefits Compared to Analogues

Benefits: Lamal offers effective pain relief with a lower risk of respiratory depression compared to some traditional opioids. Its dual mechanism of action provides a unique approach to pain management.

Suitable Patient Groups

Patient Groups: Lamal tablets may be suitable for adults, including the elderly, for the management of moderate to severe pain. Use in children should be under close medical supervision.

Storage and Shelf Life

Storage: Store Lamal tablets at room temperature, away from moisture and heat. Keep out of reach of children and pets. Check the expiration date and dispose of unused tablets properly according to local regulations.

Packaging Description

Packaging: Lamal Tablets 25 mg. №30 are typically packaged in blister packs or bottles containing 30 tablets each.

Clinical Evidence and Proven Effectiveness

Clinical Evidence: Studies have shown the efficacy of Lamal in managing pain. A study in the Journal of Pain Research demonstrated significant pain relief in patients with chronic osteoarthritis pain compared to placebo.